The Department of Biomedicine, University of Basel, Switzerland, invites qualified candidates to apply for a postdoctoral position in Biology / Immunology / Oncology.
The candidate will join a multi-disciplinary team focusing on major signaling pathways in cancer and inflammation.
Main targets are stress kinases vital for metabolic control and immune checkpoint modulation in cancer therapy. The candidate will also be involved in the development of new bioactive molecules, a process supported by our team of chemists.
The working place of the successful candidate is the Department of Biomedicine at Mattenstrasse 28, 4057 Basel.
We are looking for candidates with
Applicants with previous expertise in immunology and / or cancer immunology are especially encouraged to apply.
Candidate's Ph.D. should not be more than four (max. five) year in the past.
The successful candidate holds a PhD in immunology, biology, biochemistry and / or molecular biology, an MD Ph.D. in medicine or a related discipline.
The position is funded for two years, and an initial one-year contract can be extended based on performance. The candidate is encouraged to acquire personal grants.
Salary will commiserate with experience (based on the Swiss National Science Foundation Postdoc salary scale).
Project examples in brief : i) role of PI3Kγ complexes in allergy, metabolic control, obesity, diabetes and cancer. ii) highly specific targeting of PI3Kα using novel chemical probes and degraders in cancer and metabolism, dissection of adverse effects.
We offer you
University of Basel is an equal opportunity employer. Salaries are according to the staff-regulations and depend on the qualifications and experience of the candidate.
Application / Contact
We look forward to receiving your application with CV, motivation letter, and the names and addresses of 2-3 referees via the online application portal.
Applications sent by Email will not be considered. For project related issues send inquires to Prof. M. Wymann via recruitment lipidsignaling.
org . Mandatory : add subject line "DBM-9 / 2021-BioImmuno".
Candidates will be evaluated on a "first-come, first-served basis", and the recruitment process will be terminated as soon the ideal candidate is identified.